View clinical trials related to Lung Transplant; Complications.
Filter by:The aim of this study is to assess the utility of nintedanib therapy in addition to usual transplant care in single lung transplant recipients with idiopathic pulmonary fibrosis (IPF). The investigators hypothesize that in IPF subjects who undergo single lung transplantation the administration of nintedanib 150 mg twice daily in addition to usual transplant care will result in better preservation of lung function at 24 months.
This study seeks to compare outcomes of 2 different methods of cardiopulmonary support during lung transplant surgeries.